Vermont § 2022 - Definitions As used in this chapter:

§ 2022. Definitions As used in this chapter:

• (1) “Blood” means whole blood collected from a single donor and processed either for transfusion
  or further manufacturing. (2) “Blood component” means that part of blood separated by physical or mechanical means. (3) “Board of Pharmacy” or “Board” means the Vermont State Board of Pharmacy. (4) “Disciplinary action” or “disciplinary cases” includes any action taken by the Board
  against a licensee or others premised upon a finding of unprofessional conduct by
  the licensee. It includes all sanctions of any kind, including obtaining injunctions,
  issuing warnings, and other similar sanctions. (5) “Dispense” or “dispensing” means the preparation and delivery of a prescription drug
  pursuant to a lawful order of a practitioner in a suitable container appropriately
  labeled for subsequent administration to or use by a patient or other individual entitled
  to receive the prescription drug. (6) “Drug” means: (A) articles recognized as drugs in the official U.S. Pharmacopoeia, official national
  formulary, official homeopathic pharmacopoeia, other drug compendium, or any supplement
  to any of them; (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention
  of disease in humans; (C) articles (other than food) intended to affect the structure or any function of the
  body of humans; and (D) articles intended for use as a component of any articles specified in subdivision
  (A), (B), or (C) of this subdivision (6). (7) “Drug outlet” means all pharmacies, wholesalers, manufacturers, and other entities
  that are engaged in the manufacture, dispensing, delivery, or distribution of prescription
  drugs. (8) “Drug sample” means a unit of a prescription drug that is not intended to be sold
  and is intended to promote the sale of the drug. (9) “Financial interest” means being: (A) a licensed practitioner of pharmacy; (B) a person who deals in goods and services that are uniquely related to the practice
  of pharmacy; (C) a person who has invested anything of value in a business that provides pharmacy services;
  or (D) a person who is a parent, child, brother, sister, grandparent, or spouse of any person
  otherwise having a “financial interest” under this subsection. (10) “Manufacturer” means a person, regardless of form, engaged in the manufacturing of
  drugs or devices. (11)(A) “Manufacturing” means the production, preparation, propagation, conversion, or processing
  of a drug or device, either directly or indirectly, by extraction from substances
  of natural origin or independently by means of chemical or biological synthesis. (B) “Manufacturing” includes the packaging or repackaging of a drug or device; the labeling
  or relabeling of the container of a drug or device for resale by a pharmacy, practitioner,
  or other person; and virtual manufacturing by an entity that sells its own prescription
  drug or device without physically possessing the product. (12) “Nonprescription drugs” means nonnarcotic medicines or drugs that may be sold without
  a prescription and that are prepackaged for use by the consumer and labeled in accordance
  with the requirements of the statutes and regulations of this State and the federal
  government. (13) “Pharmacist” means an individual licensed under this chapter. (14) “Pharmacy technician” means an individual who, only while assisting and under the
  supervision of a licensed pharmacist, performs tasks relative to dispensing prescription
  drugs, administering immunizations, and performing tests for COVID-19. Pharmacy technicians
  shall administer immunizations and perform tests for COVID-19 in compliance and accordance
  with section 2042a of this title. (15)(A) “Practice of pharmacy” means: